CMI Health’s AsthmaGo® Mobile Application selected as CES® Innovation Awards Nominee
CES® 2024 Innovation Award Product
December 7th, 2023 – CMI Health, Inc. proudly announces that in recognition of its groundbreaking contribution to healthcare technology, AsthmaGo® has been announced as an Innovation Award Honoree at CES® 2024. AsthmaGo® is a groundbreaking app-based asthma management solution, transforming the way patients and healthcare professionals manage asthma by providing a comprehensive digital platform. This prestigious acknowledgment solidifies CMI Health, Inc.’s commitment to advancing the future of home health monitoring. CMI Health, Inc. (“CMI Health”) is a leading innovator in FDA-cleared medical devices and telehealth solutions, including mobile applications designed to provide easy accessibility for all users. The Consumer Technology Association (“CES”) has recognized AsthmaGo, a CMI Health Mobile application, as one of the official honorees for the prestigious Innovations Awards.
“AsthmaGo® will greatly improve patient outcomes and reduce unnecessary ER visits by giving the patients more control over their own health and offering physicians remote insights to their health data.” said JC Ren, CMI Health, Inc.’s Chief Operations Officer. “Patients can take measurements at home with CMI Health integrated devices and manage their data with a smartphone.”
AsthmaGo® Mobile Application
AsthmaGo® is an app-based asthma management platform that aims to transform the way healthcare professionals and patients alike manage their chronic conditions on a day-to-day basis.
This solution includes the integration of over-the-counter devices that simplify testing, managing, and sharing the user’s pulmonary function data and pulse oximetry data at home or on the go.
The AsthmaGo® App takes the recorded health data and aggregates it into reports, that are easily visualized by the user and remotely shared with a caregiver.
Users can also check local weather and air quality, perform Asthma Control Test, and log symptoms in the App.
CMI Health, Inc. and CES®
CES® is recognized as one of the “most powerful technology events internationally”. The highly respected event is designed to provide a platform for technological innovators and groundbreaking technology. CES® is the only tradeshow that showcases the entire tech industry and landscape at one event. For more information regarding the 2024 tradeshow, click here.
The CES® Innovation Awards program is an annual competition honoring outstanding design and engineering in consumer technology products. The program recognizes honorees in a multitude of consumer technology product categories and distinguishes the highest rated in each. CES® Innovation Awards judges are all highly respected experts in their fields and include consumer technology designers, engineers and members of the media. For a comprehensive list of the participating judges, click here.
As an honoree, CMI Health’s AsthmaGo® mobile application has been recognized as a pioneering technological product, showcasing its excellence in design and ability to address relevant issues in the telehealth landscape.
“The AsthmaGo App showcased innovative features and now joins the special group of other products given this honor.” -CES
About CMI Health
CMI Health is an Alpharetta, Georgia based company dedicated to providing medical professionals and at-home users with innovative, non-invasive health monitoring devices at an affordable price. Our products empower users to take control of their own health, enabling them to make informed health decisions when it matters most. We offer a wide variety of accurate, reliable, and FDA Cleared monitoring devices, that can be used to measure and monitor oxygen saturation, blood pressure, temperature, ECG, glucose, peak flow, FEV1, ETCO2, respiration rate, and more. These devices are well suited for both professional healthcare environments and simple at home (or on the go) use.
Our products are ideal for individuals seeking to monitor their overall well-being, or those with chronic health conditions such as Asthma, COPD, Sleep Apnea, hypertension, diabetes, lung diseases, or cardiovascular diseases. However, the resulting benefits of owning a health monitoring device, such as a pulse oximeter, are not strictly limited to those with chronic health or respiratory conditions. For more information visit www.cmihealth.com.”
<Contact Information – CMI Health>
For more information about CMI Health, please contact George Lorenz at (678) 442-7167 or email@example.com.
<Contact Information – CES®>
For more information about the CES event, please visit https://www.ces.tech/about-ces.aspx
- CMI Health’s AsthmaGo® Mobile Application selected as CES® Innovation Awards Nominee
- CMI Health, Inc. at AARC 2023
- CMI Health, Inc. Launches AsthmaGo®, Redefining Asthma Management and the Future of Remote Patient Monitoring
- CMI Health, Inc. at ATS 2023
- CMI Health, Inc. at ATA 2023
- CMI Health, Inc. at CES 2023
- CMI Health, Inc. at ATS 2022
- CMI Health, Inc. at ATA 2022
- CMI Health, Inc. at HIMSS 2022
- AsthmaGo App Wins Third Place in IEEE Telehealth Competition
- CMI Health is Proud to Introduce AsthmaGo
- CMI Health, Inc at CES 2022